Procaina Labesfal (Procaine)
Procaina Labesfal (Procaine) Uses, Dosage, Side Effects, Food Interaction and all others data.
A local anesthetic of the ester type that has a slow onset and a short duration of action. It is mainly used for infiltration anesthesia, peripheral nerve block, and spinal block. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1016). Procaina Labesfal (Procaine) has also been investigated as an oral entry inhibitor in treatment-experienced HIV patients .
Procaina Labesfal (Procaine) is an anesthetic agent indicated for production of local or regional anesthesia, particularly for oral surgery. Procaina Labesfal (Procaine) (like cocaine) has the advantage of constricting blood vessels which reduces bleeding, unlike other local anesthetics like lidocaine. Procaina Labesfal (Procaine) is an ester anesthetic. It is metabolized in the plasma by the enzyme pseudocholinesterase through hydrolysis into para-aminobenzoic acid (PABA), which is then excreted by the kidneys into the urine.
Trade Name | Procaina Labesfal (Procaine) |
Availability | Discontinued |
Generic | Procaine |
Procaine Other Names | Novocaine, Procaina, Procaine, Procainum, Vitamin H3 |
Related Drugs | lidocaine ophthalmic, cocaine nasal, bupivacaine |
Type | |
Formula | C13H20N2O2 |
Weight | Average: 236.3101 Monoisotopic: 236.152477894 |
Groups | Approved, Investigational, Vet approved |
Therapeutic Class | |
Manufacturer | |
Available Country | Portugal |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Procaina Labesfal (Procaine) is a local anesthetic used for anesthesia, peripheral nerve block, and spinal nerve block.
Used as a local anesthetic primarily in oral surgery
Procaina Labesfal (Procaine) is also used to associated treatment for these conditions: Otalgia
How Procaina Labesfal (Procaine) works
Procaina Labesfal (Procaine) acts mainly by inhibiting sodium influx through voltage gated sodium channels in the neuronal cell membrane of peripheral nerves. When the influx of sodium is interrupted, an action potential cannot arise and signal conduction is thus inhibited. The receptor site is thought to be located at the cytoplasmic (inner) portion of the sodium channel. Procaina Labesfal (Procaine) has also been shown to bind or antagonize the function of N-methyl-D-aspartate (NMDA) receptors as well as nicotinic acetylcholine receptors and the serotonin receptor-ion channel complex.
Food Interaction
No interactions found.Procaina Labesfal (Procaine) Drug Interaction
Moderate: lorazepamUnknown: aspirin, epinephrine, docusate, duloxetine, dexamethasone, dextran, low molecular weight, ginkgo, arginine, escitalopram, acetaminophen, acetaminophen / oxycodone, topiramate, acetaminophen, multivitamin, cyanocobalamin, riboflavin, pyridoxine, ascorbic acid, cholecalciferol
Procaina Labesfal (Procaine) Disease Interaction
Half Life
7.7 minutes
Elimination Route
With normal kidney function, the drug is excreted rapidly by tubular excretion.
Innovators Monograph
You find simplified version here Procaina Labesfal (Procaine)